These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 11008250)

  • 21. Targeted agents for adjuvant therapy of colon cancer.
    de Gramont A; Tournigand C; André T; Larsen AK; Louvet C
    Semin Oncol; 2006 Dec; 33(6 Suppl 11):S42-5. PubMed ID: 17178286
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lessons learned from independent central review.
    Ford R; Schwartz L; Dancey J; Dodd LE; Eisenhauer EA; Gwyther S; Rubinstein L; Sargent D; Shankar L; Therasse P; Verweij J
    Eur J Cancer; 2009 Jan; 45(2):268-74. PubMed ID: 19101138
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The potential prognostic, predictive, and therapeutic values of DNA methylation in cancer. Commentary re: J. Kwong et al., Promoter hypermethylation of multiple genes in nasopharyngeal carcinoma. Clin. Cancer Res., 8: 131-137, 2002, and H-Z. Zou et al., Detection of aberrant p16 methylation in the serum of colorectal cancer patients. Clin. Cancer Res., 8: 188-191, 2002.
    Widschwendter M; Jones PA
    Clin Cancer Res; 2002 Jan; 8(1):17-21. PubMed ID: 11801535
    [No Abstract]   [Full Text] [Related]  

  • 24. Cancer prevention by delay. Commentary re: J. A. O'Shaughnessy et al., Treatment and Prevention of Intraepithelial Neoplasia: An Important Target for Accelerated New Agent Development. Clin. Cancer Res., 8: 314-346, 2002.
    Lippman SM; Hong WK
    Clin Cancer Res; 2002 Feb; 8(2):305-13. PubMed ID: 11839646
    [No Abstract]   [Full Text] [Related]  

  • 25. Laparoscopically assisted colectomy is as safe and effective as open colectomy in people with colon cancer Abstracted from: Nelson H, Sargent D, Wieand HS, et al; for the Clinical Outcomes of Surgical Therapy Study Group. A comparison of laparoscopically assisted and open colectomy for colon cancer. N Engl J Med 2004; 350: 2050-2059.
    Cancer Treat Rev; 2004 Dec; 30(8):707-9. PubMed ID: 15541580
    [No Abstract]   [Full Text] [Related]  

  • 26. FOLFOX for stage II colon cancer? A commentary on the recent FDA approval of oxaliplatin for adjuvant therapy of stage III colon cancer.
    Grothey A; Sargent DJ
    J Clin Oncol; 2005 May; 23(15):3311-3. PubMed ID: 15908645
    [No Abstract]   [Full Text] [Related]  

  • 27. Commentary on 'Radical surgery for rectal Cancer' by cohen.
    Goldberg SM
    Surg Oncol Clin N Am; 2000 Oct; 9(4):749-50. PubMed ID: 11008240
    [No Abstract]   [Full Text] [Related]  

  • 28. Commentary on 'Current protocols and outcomes for colonic Cancer' by guleserian and bland.
    Gemlo BT
    Surg Oncol Clin N Am; 2000 Oct; 9(4):739-40. PubMed ID: 11008238
    [No Abstract]   [Full Text] [Related]  

  • 29. Adjuvant chemotherapy for colon cancer: evidence on improvement in survival.
    Samantas E; Dervenis C; Rigatos SK
    Dig Dis; 2007; 25(1):67-75. PubMed ID: 17384510
    [TBL] [Abstract][Full Text] [Related]  

  • 30. New HER2-directed therapies for breast cancer. Commentary re: C. I. Spiridon et al., Targeting multiple Her-2 epitopes with monoclonal antibodies results in improved antigrowth activity. Clin. Cancer Res., 8: 1720-1730, 2002.
    Frankel AE
    Clin Cancer Res; 2002 Jun; 8(6):1699-701. PubMed ID: 12060606
    [No Abstract]   [Full Text] [Related]  

  • 31. Trustworthy alteration and improvement in adjuvant treatment of colon cancer.
    Harlak A; Soran A
    Med Sci Monit; 2006 Mar; 12(3):RA46-52. PubMed ID: 16501433
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Targeting the mitochondria: an exciting new approach to myeloma therapy. Commentary re: N. J. Bahlis et al., Feasibility and correlates of arsenic trioxide combined with ascorbic acid-mediated depletion of intracellular glutathione for the treatment of relapsed/refractory multiple myeloma. Clin. Cancer Res., 8: 3658-3668, 2002.
    Dalton WS
    Clin Cancer Res; 2002 Dec; 8(12):3643-5. PubMed ID: 12473572
    [No Abstract]   [Full Text] [Related]  

  • 33. Clinical overview: adjuvant therapy of gastrointestinal cancer.
    Macdonald JS
    Cancer Chemother Pharmacol; 2004 Sep; 54 Suppl 1():S4-11. PubMed ID: 15309508
    [TBL] [Abstract][Full Text] [Related]  

  • 34. New approaches to assessing and treating early-stage colon and rectal cancers: cooperative group strategies for assessing optimal approaches in early-stage disease.
    Benson AB
    Clin Cancer Res; 2007 Nov; 13(22 Pt 2):6913s-20s. PubMed ID: 18006800
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Young age influences treatment but not outcome of colon cancer.
    Quah HM; Joseph R; Schrag D; Shia J; Guillem JG; Paty PB; Temple LK; Wong WD; Weiser MR
    Ann Surg Oncol; 2007 Oct; 14(10):2759-65. PubMed ID: 17593332
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Allelic losses of loci at 3p25.1, 8p22, 13q12, 17p13.3, and 22q13 correlate with postoperative recurrence in breast cancer.
    Hirano A; Emi M; Tsuneizumi M; Utada Y; Yoshimoto M; Kasumi F; Akiyama F; Sakamoto G; Haga S; Kajiwara T; Nakamura Y
    Clin Cancer Res; 2001 Apr; 7(4):876-82. PubMed ID: 11309336
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pooled analysis of fluorouracil-based adjuvant therapy for stage II and III colon cancer: who benefits and by how much?
    Gill S; Loprinzi CL; Sargent DJ; Thomé SD; Alberts SR; Haller DG; Benedetti J; Francini G; Shepherd LE; Francois Seitz J; Labianca R; Chen W; Cha SS; Heldebrant MP; Goldberg RM
    J Clin Oncol; 2004 May; 22(10):1797-806. PubMed ID: 15067028
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of patients with high-risk stage II colon cancer for adjuvant therapy.
    Quah HM; Chou JF; Gonen M; Shia J; Schrag D; Landmann RG; Guillem JG; Paty PB; Temple LK; Wong WD; Weiser MR
    Dis Colon Rectum; 2008 May; 51(5):503-7. PubMed ID: 18322753
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Author commentary on Dirk Horenkamp-Sonntag et al.
    Endoscopy; 2020 Dec; 52(12):v49. PubMed ID: 33238322
    [No Abstract]   [Full Text] [Related]  

  • 40. Commentary on Zvonareva et al.
    Dresser R
    Clin Trials; 2015 Dec; 12(6):654-6. PubMed ID: 26555682
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.